The alternative text for this image may have been generated using AI. Knowledge of the determinants of antithrombin specificity and the size requirement for bridging thrombin has led to the ...

Thrombin potently activates platelets through the protease-activated receptor PAR-1. Vorapaxar is a novel antiplatelet agent that selectively inhibits the cellular actions of thrombin through ...

If you get a blood clot in your leg or another large blood vessel called a deep vein thrombosis (DVT), your treatment will include medications known as blood thinners. These drugs, also called ...

After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the biologic ...

The glycoprotein V of the blood platelets is an important switch point for haemostasis and thrombus formation. This new finding could have great clinical potential. When our blood vessels are injured ...

Immunothrombosis, or the formation of microscopic blood clots during inflammation, is a major cause of morbidity among patients with sepsis or severe COVID-19. A key enzyme in this process is thrombin ...